Page last updated: 2024-11-04

sulfamethoxazole and Carcinoma, Ehrlich Tumor

sulfamethoxazole has been researched along with Carcinoma, Ehrlich Tumor in 1 studies

Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.

Carcinoma, Ehrlich Tumor: A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Sahyon, HAE1
Ramadan, ENM1
Althobaiti, F1
Mashaly, MMA1

Other Studies

1 other study available for sulfamethoxazole and Carcinoma, Ehrlich Tumor

ArticleYear
Anti-proliferative effects of the combination of Sulfamethoxazole and Quercetin via caspase3 and NFkB gene regulation: an in vitro and in vivo study.
    Naunyn-Schmiedeberg's archives of pharmacology, 2022, Volume: 395, Issue:2

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Ehrlich Tumor; Caspas

2022